28 marzo 2015
Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the cancer’s return.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/8jal_Oo2fOI/150328102418.htm
